TAFAZZIN and synovial sarcoma: For example, the SS18::SSX fusion protein of synovial sarcomas dysregulates the Hippo pathway through an insulin growth factor signaling axis to drive YAP/TAZ activation and YAP-/TAZ-/TEAD-dependent tumor growth (Isfort et al. 2019).